Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

Dr Petros Grivas reflects on ASCO 2025 highlights, including new data on PARP inhibitors and the growing importance of biomarker-driven treatment.

The company announced topline results from a pre-specified interim analysis of the Phase III PSMAddition trial on June 2, reporting that the trial met its primary endpoint. It demonstrated a ...

The Los Angeles Dodgers are full of superstars, but Hyeseong Kim has been a key part of their success in 2025.

As the Miami Heat bring in rookie guard Kasparas Jakucionis, fans and analysts alike are detailing what he could potentially bring to the team. He'll have the f ...

CLEVELAND, Ohio — In an offseason dotted with departures, the Cavs have made an addition to their coaching staff.

BCCI To Make Last Minute Addition In India Test Squad vs England? India A Star Asked To Stay Back: Report Only four days remain for India's five-Test series against England to start ...

CINCINNATI — ESPN's Aaron Schatz dropped one final offseason move each NFL team should check off the board before training camp, keeping things in-house for the Bengals. Cincinnati needs to get ...

The Kansas City Chiefs weren't particularly busy in free agency, but one of their marquee additions already looks destined to be a disappointment for the team.

As Phillies’ injuries and other absences continue to pile up, some early-season concerns are being revisited.

The Denver Broncos recently brought J.K. Dobbins into the fold, and the former Los Angeles Chargers running back may be getting the bulk of the snaps.